Target intelligence / Profile preview

Glycogen synthase (liver isoform) (GYS2)

Target
GYS2
Molecular classification
Enzyme, Glycosyltransferase (GT3 family in mammals)
01

Overview

Glycogen synthase is the key regulatory enzyme in the hepatic glycogen synthesis pathway, catalyzing the elongation of α-1,4-linked glucose chains from UDP-glucose onto a growing glycogen polymer[3][6][7][9]. The liver isoform (GYS2) is essential for maintaining blood glucose homeostasis, particularly during fasting. Glycogen synthesis is initiated by glycogenin, which acts as a primer; glycogen synthase extends these chains, and the branching enzyme introduces α-1,6-linkages[6][9]. GYS2 activity is tightly regulated by reversible phosphorylation and by allosteric signals—primarily glucose-6-phosphate—thus integrating hormonal (insulin/glucagon), nutritional, and cellular energy cues[1][2][3]. Aberrations in this pathway are implicated in diabetes, insulin resistance, and various glycogen storage disorders[9]. As such, the enzyme and pathway represent important therapeutic targets for metabolic disease intervention.

Other names
Glycogen synthase 2UDP-glucose:glycogen glucosyltransferaseGYS2 (liver isoform)
02

Mechanism of action

Allosteric activation by glucose-6-phosphate; Inhibition by phosphorylation (primarily by glycogen synthase kinase-3 and other kinases)

03

Biological functions

Glycogenesis (glycogen biosynthesis)Glucose homeostasisEnergy storage
04

Disease associations

Diabetes mellitusGlycogen storage diseases (especially GSD 0)Metabolic syndromeInsulin resistance
05

Safety considerations

Hypoglycemia risk from excessive activationHepatic steatosis and glycogen overload if not correctly regulatedSecondary metabolic derangements in glycogen storage disorders
06

Interacting drugs

Insulin (activates via signaling, not a direct binder)

2 more in the full profile.

07

Biomarkers

Hepatic glycogen content (measured indirectly by imaging or biopsies)Blood glucose levels (as a functional readout)Phosphorylation status of GYS2

Beyond the preview

Go deeper on Glycogen synthase (liver isoform) (GYS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycogen synthase (liver isoform) (GYS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call